MOMENTA PHARMACEUTICALS INC's ticker is MNTA and the CUSIP is 60877T100. A total of 148 filers reported holding MOMENTA PHARMACEUTICALS INC in Q2 2016. The put-call ratio across all filers is 0.14 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $11,284,000 | +2001.3% | 215,023 | +1231.9% | 0.55% | +1720.0% |
| Q2 2020 | $537,000 | +168.5% | 16,144 | +119.6% | 0.03% | +130.8% |
| Q1 2020 | $200,000 | -83.1% | 7,353 | -83.7% | 0.01% | -81.2% |
| Q3 2018 | $1,184,000 | +1108.2% | 45,000 | +510.7% | 0.07% | +666.7% |
| Q1 2017 | $98,000 | -58.3% | 7,369 | -63.4% | 0.01% | -64.0% |
| Q3 2016 | $235,000 | +370.0% | 20,117 | +272.4% | 0.02% | +257.1% |
| Q1 2016 | $50,000 | -10.7% | 5,402 | +42.2% | 0.01% | -22.2% |
| Q4 2015 | $56,000 | +14.3% | 3,800 | -11.6% | 0.01% | +28.6% |
| Q3 2014 | $49,000 | -52.4% | 4,300 | -49.4% | 0.01% | -50.0% |
| Q2 2014 | $103,000 | +347.8% | 8,500 | +325.0% | 0.01% | +366.7% |
| Q1 2014 | $23,000 | -78.5% | 2,000 | -67.0% | 0.00% | -83.3% |
| Q4 2013 | $107,000 | +23.0% | 6,069 | 0.0% | 0.02% | +28.6% |
| Q3 2013 | $87,000 | -62.0% | 6,069 | -60.2% | 0.01% | -71.4% |
| Q2 2013 | $229,000 | -65.8% | 15,232 | -69.7% | 0.05% | -60.8% |
| Q1 2013 | $670,000 | – | 50,232 | – | 0.12% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Opaleye Management Inc. | 450,000 | $7,605,000 | 3.18% |
| ARMISTICE CAPITAL, LLC | 820,000 | $13,858,000 | 1.77% |
| Marcus Capital, LLC | 104,000 | $1,758,000 | 1.50% |
| SECTOR GAMMA AS | 605,545 | $10,234,000 | 1.49% |
| Palo Alto Investors LP | 1,787,576 | $30,210,000 | 1.41% |
| SECTORAL ASSET MANAGEMENT INC | 299,400 | $5,060,000 | 0.55% |
| BOGLE INVESTMENT MANAGEMENT L P /DE/ | 433,060 | $7,318,000 | 0.53% |
| DISCOVERY CAPITAL MANAGEMENT, LLC / CT | 1,232,929 | $20,837,000 | 0.51% |
| Orbimed Advisors | 2,109,068 | $35,643,000 | 0.37% |
| TFS CAPITAL LLC | 52,290 | $884,000 | 0.35% |